WuXi Biologics (Cayman) (WXXWY) to Release Earnings on Tuesday

WuXi Biologics (Cayman) (OTCMKTS:WXXWY) is anticipated to post its results before the market opens on Tuesday, March 24th. Analysts expect WuXi Biologics (Cayman) to post earnings of $0.1823 per share and revenue of $1.7123 billion for the quarter.

WuXi Biologics (Cayman) Stock Performance

Shares of OTCMKTS WXXWY opened at $8.84 on Tuesday. The stock’s 50-day moving average is $9.77 and its two-hundred day moving average is $9.31. WuXi Biologics has a 1-year low of $4.14 and a 1-year high of $11.21.

About WuXi Biologics (Cayman)

WuXi Biologics (Cayman) Inc, trading OTC as WXXWY, is a global contract research, development and manufacturing organization (CDMO) specializing in biologics. Founded as a spin-out from WuXi AppTec and incorporated in the Cayman Islands in 2017, the company offers end-to-end support across the biologics value chain. Its service portfolio encompasses discovery biology, analytical development, process chemistry and large-scale manufacturing for therapeutic proteins and antibodies.

The firm’s core offerings include the development of monoclonal antibodies, recombinant proteins and cell and gene therapy vectors.